Reports for MARCAN PHARMACEUTICALS INC
Company Name
MARCAN PHARMACEUTICALS INC
Totals |
||
Shortage reports |
263 |
|
| Actual shortage: | 54 (21%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 4 (2%) | |
| Resolved: | 205 (78%) | |
Discontinuation Reports |
31 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 31 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
63 (21%) |
|
Overdue reports |
2 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MAR-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-08-29 | 2019-09-10 | 92576 |
| MAR-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-18 | 2020-03-21 | 106554 |
| MAR-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-18 | 2020-03-21 | 106559 |
| MAR-ESCITALOPRAM | 20MG | TABLET | Resolved | 2017-03-13 | 2018-07-06 | 919 |
| MAR-ESCITALOPRAM | 20MG | TABLET | Resolved | 2017-03-13 | 2017-06-12 | 925 |
| MAR-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-03-07 | 2019-09-10 | 42193 |
| MAR-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-01-10 | 2019-03-15 | 71818 |
| MAR-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-18 | 2020-05-06 | 106568 |
| MAR-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-05-20 | 2022-07-20 | 139675 |
| MAR-CETIRIZINE | 10MG | TABLET | Resolved | 2017-11-30 | 2020-03-25 | 31334 |
| MAR-CETIRIZINE | 20MG | TABLET | Resolved | 2017-11-30 | 2018-06-06 | 31338 |
| MAR-CETIRIZINE | 20MG | TABLET | Resolved | 2017-12-14 | 2018-07-05 | 32927 |
| MAR-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-06-12 | 2018-08-25 | 12565 |
| MAR-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-06-12 | 2018-08-25 | 12568 |
| MAR-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2017-03-13 | 2017-07-15 | 971 |
| MAR-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2017-03-13 | 2017-07-15 | 978 |
| MAR-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2017-11-30 | 2018-09-06 | 31323 |
| MAR-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2018-04-27 | 2018-09-06 | 47345 |
| MAR-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-13 | 2017-08-29 | 962 |
| MAR-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-13 | 2017-08-29 | 967 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MAR-DONEPEZIL | 5MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148014 |
| MAR-DONEPEZIL | 10MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148021 |
| MAR-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148097 |
| MAR-METFORMIN | 500MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148109 |
| MAR-METFORMIN | 850MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148112 |
| MAR-METFORMIN | 500MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148115 |
| MAR-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2021-10-26 | 2021-10-26 | 148118 |
| MAR-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-10-26 | 2021-10-26 | 148085 |
| MAR-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-10-26 | 2021-10-26 | 148088 |
| MAR-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-10-26 | 2021-10-26 | 148091 |
| MAR-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-10-26 | 2021-10-26 | 148094 |